Furthermore, the significant positive correlations between CDC27 and PTEN, PTEN and BRCA2, and PTEN and APC mutation associations and the significant negative association between the BRAF and KRAS mutations were of significant importance regarding tumor development and progression and increased resistance or sensitivity against treatments. This evidence concerns the gene PTEN and neoplasm.